Clinical significance of clusterin expression in pancreatic adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>Clusterin is known to be expressed in many human neoplasms, and is believed to participate in the regeneration, migration, and anti-apoptosis of tumor cells. However, few reports have addressed the relationship between the manifestat...

Full description

Bibliographic Details
Main Authors: Jin Junshuo, Kim Joon-Mee, Hur Yoon-Seok, Cho Won, Lee Keon-Young, Ahn Seung-Ik, Hong Kee, Park In-Sun
Format: Article
Language:English
Published: BMC 2012-07-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://www.wjso.com/content/10/1/146
_version_ 1818524518043353088
author Jin Junshuo
Kim Joon-Mee
Hur Yoon-Seok
Cho Won
Lee Keon-Young
Ahn Seung-Ik
Hong Kee
Park In-Sun
author_facet Jin Junshuo
Kim Joon-Mee
Hur Yoon-Seok
Cho Won
Lee Keon-Young
Ahn Seung-Ik
Hong Kee
Park In-Sun
author_sort Jin Junshuo
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Clusterin is known to be expressed in many human neoplasms, and is believed to participate in the regeneration, migration, and anti-apoptosis of tumor cells. However, few reports have addressed the relationship between the manifestation of clusterin and clinicopathologic parameters in pancreas cancer patients. In the present study, the authors investigated the expression of clusterin and its clinical significance in pancreatic adenocarcinoma.</p> <p>Methods</p> <p>Immunohistochemical staining was performed for clusterin in tumor tissues obtained from patients who received pancreatic resection with radical intent, and the associations of clusterin expression with various clinicopathologic parameters were analyzed in addition to the relation between its expression and survival.</p> <p>Results</p> <p>Immunoreactivity for clusterin was observed in 17 of the 52 (33%) pancreatic adenocarcinomas examined. In addition, clusterin positivity was found to be associated with preoperative serum carcinoembryonic antigen level, perineural invasion, and, most strongly, lymph node metastasis. The survival analysis identified tumor differentiation and lymph node metastasis as the only significant prognostic factors.</p> <p>Conclusion</p> <p>Although not an independent prognostic factor, clusterin immunoreactivity can be used in conjunction with lymph node metastasis to predict survival in cases of pancreatic adenocarcinoma.</p>
first_indexed 2024-12-11T05:58:07Z
format Article
id doaj.art-3d237004a3994a3b93bd14f001631a64
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-11T05:58:07Z
publishDate 2012-07-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-3d237004a3994a3b93bd14f001631a642022-12-22T01:18:35ZengBMCWorld Journal of Surgical Oncology1477-78192012-07-0110114610.1186/1477-7819-10-146Clinical significance of clusterin expression in pancreatic adenocarcinomaJin JunshuoKim Joon-MeeHur Yoon-SeokCho WonLee Keon-YoungAhn Seung-IkHong KeePark In-Sun<p>Abstract</p> <p>Background</p> <p>Clusterin is known to be expressed in many human neoplasms, and is believed to participate in the regeneration, migration, and anti-apoptosis of tumor cells. However, few reports have addressed the relationship between the manifestation of clusterin and clinicopathologic parameters in pancreas cancer patients. In the present study, the authors investigated the expression of clusterin and its clinical significance in pancreatic adenocarcinoma.</p> <p>Methods</p> <p>Immunohistochemical staining was performed for clusterin in tumor tissues obtained from patients who received pancreatic resection with radical intent, and the associations of clusterin expression with various clinicopathologic parameters were analyzed in addition to the relation between its expression and survival.</p> <p>Results</p> <p>Immunoreactivity for clusterin was observed in 17 of the 52 (33%) pancreatic adenocarcinomas examined. In addition, clusterin positivity was found to be associated with preoperative serum carcinoembryonic antigen level, perineural invasion, and, most strongly, lymph node metastasis. The survival analysis identified tumor differentiation and lymph node metastasis as the only significant prognostic factors.</p> <p>Conclusion</p> <p>Although not an independent prognostic factor, clusterin immunoreactivity can be used in conjunction with lymph node metastasis to predict survival in cases of pancreatic adenocarcinoma.</p>http://www.wjso.com/content/10/1/146PancreasAdenocarcinomaClusterinSurvival
spellingShingle Jin Junshuo
Kim Joon-Mee
Hur Yoon-Seok
Cho Won
Lee Keon-Young
Ahn Seung-Ik
Hong Kee
Park In-Sun
Clinical significance of clusterin expression in pancreatic adenocarcinoma
World Journal of Surgical Oncology
Pancreas
Adenocarcinoma
Clusterin
Survival
title Clinical significance of clusterin expression in pancreatic adenocarcinoma
title_full Clinical significance of clusterin expression in pancreatic adenocarcinoma
title_fullStr Clinical significance of clusterin expression in pancreatic adenocarcinoma
title_full_unstemmed Clinical significance of clusterin expression in pancreatic adenocarcinoma
title_short Clinical significance of clusterin expression in pancreatic adenocarcinoma
title_sort clinical significance of clusterin expression in pancreatic adenocarcinoma
topic Pancreas
Adenocarcinoma
Clusterin
Survival
url http://www.wjso.com/content/10/1/146
work_keys_str_mv AT jinjunshuo clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT kimjoonmee clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT huryoonseok clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT chowon clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT leekeonyoung clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT ahnseungik clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT hongkee clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma
AT parkinsun clinicalsignificanceofclusterinexpressioninpancreaticadenocarcinoma